Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Benzodiazepine bromodomain inhibitor

Benzodiazepine bromodomain inhibitor

US Patent 9102677 · Granted Aug 11, 2015

Estimated economic value: $21,213,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

3-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl) propanoic acid derivatives as KMO inhi2025
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 2023
3-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl) propanoic acid derivatives as KMO inhi2022
5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 2021
5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMT2020
Method of treating pancreatitis using 1,4-benzoxazine derivatives2020
Prodrug of 1,1′-(1,6-dioxo-1,6-hexanediyl)bis-D-proline2020
5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS2020
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 2019
D-proline derivatives as SAP depleting agent2019
3-(6-chloro-3-oxo-3,4-dihydro-(2H)-1,4-benzoxazin-4-yl) propanoic acid derivativ2019
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 2018